Hot Runners: Inovio Pharmaceuticals (NASDAQ:INO), Citigroup Inc. (NYSE:C), Heartland Financial USA (NASDAQ:HTLF), Chico’s FAS Inc. (NYSE:CHS), Sprint Corporation (NYSE:S)


Inovio Pharmaceuticals, has initiated a phase I trial of its hTERT DNA immunotherapy (INO-1400) alone or in combination with Inovio’s IL-12 immune activator (INO-9012) in adults with breast, lung, or pancreatic cancer at high risk of relapse after surgery and other cancer treatments. Because high levels of hTERT (human telomerase reverse transcriptase) expression are found in 85 per cent of human cancers, Inovio’s cancer candidate holds the potential as a broad spectrum cancer therapeutic. Inovio Pharmaceuticals, Inc. (NASDAQ:INO) in last trading activity advanced 5.22% to close at $9.48. Company weekly performance is 11.66% while its quarterly performance stands at -6.32%. Inovio Pharmaceuticals, Inc. (NASDAQ:INO) is -40.00% away from its 52 week high.

John Gerspach, Chief Financial Officer, and Eric Aboaf, Treasurer, will conduct the Citigroup Inc. (NYSE:C) fourth quarter 2014 Fixed Income Investor Review at 11:00 AM (ET) on Friday, January 23, 2015. The review will be available live via webcast and teleconference. Citigroup Inc. (NYSE:C) in last trading activity fell -0.17% to close at $54.01. Company weekly performance is 1.14% while its quarterly performance stands at 1.85%. Citigroup Inc. (NYSE:C) is -5.16% away from its 52 week high.

On December 12, Heartland Financial USA, Inc. (NASDAQ:HTLF) announced the pricing of a private offering of $75 million aggregate principal amount of 5.75% Subordinated Notes due 2024 (the “Notes”), at par. The Notes were offered only to qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and to institutional accredited investors in a manner exempt from registration under the Securities Act. On last trading day Heartland Financial USA, Inc. (NASDAQ:HTLF) advanced 0.89% to close at $27.19. Its volatility for the week is 2.59% while volatility for the month is 2.61%. HTLF’s sales growth for past 5 years was -0.30% and its EPS growth for past 5 years was 24.60%. Heartland Financial USA, Inc. (NASDAQ:HTLF) monthly performance is 5.88%.

Shares of Chico’s FAS Inc (NYSE:CHS) have received a consensus recommendation of “Buy” from the twelve brokerages that are covering the stock, AmericanBankingNews.com reports. Five equities research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. Chico’s FAS Inc. (NYSE:CHS) has 1.40% insider ownership while its institutional ownership stands at 92.80%. In last trading activity company’s stock closed at $15.73.

Sprint Corporation (NYSE:S) was the target of a significant decline in short interest in November. As of November 28th, there was short interest totalling 65,961,815 shares, a decline of 15.2% from the November 14th total of 77,742,838 shares, AnalystRatings.NET reports. Based on an average daily volume of 4,333,465 shares. On last trading day Sprint Corporation (NYSE:S) advanced 1.96% to close at $4.16. Its volatility for the week is 4.93% while volatility for the month is 4.45%. S’s sales EPS growth for past 5 years was -73.48%. Sprint Corporation (NYSE:S) monthly performance is -11.68%.


Leave a Reply

Your email address will not be published. Required fields are marked *